EMEA-001356-PIP02-12-M02

Key facts

Invented name
Clensia
Active substance
Citric acid (as citric acid anhydrous) / sodium chloride / simeticone / macrogol 4000 / sodium citrate /sodium sulfate (as sodium sulfate anhydrous) / potassium chloride (PMF104)
Therapeutic area
Gastroentology-Hepatology
Decision number
P/0223/2018
PIP number
EMEA-001356-PIP02-12-M02
Pharmaceutical form(s)
Powder for oral suspension
Condition(s) / indication(s)
Bowel cleansing prior to clinical procedures
Route(s) of administration
Oral use
Contact for public enquiries
Alfa Wassermann S.p.A. 

Tel. +39 0516489602 
E-mail: antonietta.pazardjiklian@alfasigma.com

Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating